FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2007305540> ?p ?o ?g. }

• W2007305540 endingPage "624" @default.
• W2007305540 startingPage "617" @default.
• W2007305540 abstract "Advanced glycation endproducts (AGEs) and their receptors, receptor for advanced glycation endproducts (RAGE), are novel groups of molecules with roles in inflammation, cytokine activation, and promotion of cell growth. Recently, RAGE has been implicated in the progression and metastasis of several epithelial tumors. The expression of RAGE was examined in 38 oral squamous cell carcinoma (OSCC) cases by immunohistochemistry. In the OSCCs, RAGE positivity, interpreted as more than 25% positive cells, was detected in 10 of 10 well-differentiated, 3 of 4 well-to-moderately differentiated, 3 of 9 moderately differentiated, 1 of 7 moderate-to-poorly differentiated, and 0 of 8 poorly differentiated tumors. The staining percentage was significantly higher in well-differentiated tumors compared to moderately (P < .05) and poorly differentiated (P < .05) tumors. All normal mucosa samples were RAGE-positive. Western blot analysis for RAGE was performed on 2 OSCCs and 2 normal oral mucosa samples. Higher expression was observed in the normal tissues compared to the OSCCs. Our results show that RAGE immunoreactivity correlates with histologic differentiation in OSCC. Advanced glycation endproducts (AGEs) and their receptors, receptor for advanced glycation endproducts (RAGE), are novel groups of molecules with roles in inflammation, cytokine activation, and promotion of cell growth. Recently, RAGE has been implicated in the progression and metastasis of several epithelial tumors. The expression of RAGE was examined in 38 oral squamous cell carcinoma (OSCC) cases by immunohistochemistry. In the OSCCs, RAGE positivity, interpreted as more than 25% positive cells, was detected in 10 of 10 well-differentiated, 3 of 4 well-to-moderately differentiated, 3 of 9 moderately differentiated, 1 of 7 moderate-to-poorly differentiated, and 0 of 8 poorly differentiated tumors. The staining percentage was significantly higher in well-differentiated tumors compared to moderately (P < .05) and poorly differentiated (P < .05) tumors. All normal mucosa samples were RAGE-positive. Western blot analysis for RAGE was performed on 2 OSCCs and 2 normal oral mucosa samples. Higher expression was observed in the normal tissues compared to the OSCCs. Our results show that RAGE immunoreactivity correlates with histologic differentiation in OSCC." @default.
• W2007305540 created "2016-06-24" @default.
• W2007305540 creator A5007603996 @default.
• W2007305540 creator A5012299032 @default.
• W2007305540 creator A5017868118 @default.
• W2007305540 creator A5032264474 @default.
• W2007305540 creator A5052334804 @default.
• W2007305540 creator A5064465653 @default.
• W2007305540 creator A5072778971 @default.
• W2007305540 creator A5073426576 @default.
• W2007305540 creator A5083304059 @default.
• W2007305540 date "2008-05-01" @default.
• W2007305540 modified "2023-10-18" @default.
• W2007305540 title "The expression of the receptor for glycation endproducts (RAGE) in oral squamous cell carcinomas" @default.
• W2007305540 cites W1492225083 @default.
• W2007305540 cites W1511842456 @default.
• W2007305540 cites W1944130357 @default.
• W2007305540 cites W1969528363 @default.
• W2007305540 cites W1974069520 @default.
• W2007305540 cites W1975151412 @default.
• W2007305540 cites W1976044794 @default.
• W2007305540 cites W1976711061 @default.
• W2007305540 cites W1982019987 @default.
• W2007305540 cites W1983701023 @default.
• W2007305540 cites W1993073412 @default.
• W2007305540 cites W2001620386 @default.
• W2007305540 cites W2007747984 @default.
• W2007305540 cites W2012570394 @default.
• W2007305540 cites W2013635556 @default.
• W2007305540 cites W2014722504 @default.
• W2007305540 cites W2017125905 @default.
• W2007305540 cites W2030015373 @default.
• W2007305540 cites W2032298886 @default.
• W2007305540 cites W2037375428 @default.
• W2007305540 cites W2046167879 @default.
• W2007305540 cites W2050555482 @default.
• W2007305540 cites W2053969514 @default.
• W2007305540 cites W2063638796 @default.
• W2007305540 cites W2065732500 @default.
• W2007305540 cites W2069313014 @default.
• W2007305540 cites W2069737608 @default.
• W2007305540 cites W2075166004 @default.
• W2007305540 cites W2081501450 @default.
• W2007305540 cites W2084898158 @default.
• W2007305540 cites W2106084953 @default.
• W2007305540 cites W2108762011 @default.
• W2007305540 cites W2108987561 @default.
• W2007305540 cites W2109334664 @default.
• W2007305540 cites W2115293825 @default.
• W2007305540 cites W2117273788 @default.
• W2007305540 cites W2117783767 @default.
• W2007305540 cites W2128101063 @default.
• W2007305540 cites W2134871534 @default.
• W2007305540 cites W2136497196 @default.
• W2007305540 cites W2148198816 @default.
• W2007305540 cites W2156617360 @default.
• W2007305540 doi "https://doi.org/10.1016/j.tripleo.2007.08.006" @default.
• W2007305540 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18206396" @default.
• W2007305540 hasPublicationYear "2008" @default.
• W2007305540 type Work @default.
• W2007305540 sameAs 2007305540 @default.
• W2007305540 citedByCount "18" @default.
• W2007305540 countsByYear W20073055402012 @default.
• W2007305540 countsByYear W20073055402013 @default.
• W2007305540 countsByYear W20073055402014 @default.
• W2007305540 countsByYear W20073055402015 @default.
• W2007305540 countsByYear W20073055402016 @default.
• W2007305540 countsByYear W20073055402017 @default.
• W2007305540 countsByYear W20073055402018 @default.
• W2007305540 countsByYear W20073055402022 @default.
• W2007305540 countsByYear W20073055402023 @default.
• W2007305540 crossrefType "journal-article" @default.
• W2007305540 hasAuthorship W2007305540A5007603996 @default.
• W2007305540 hasAuthorship W2007305540A5012299032 @default.
• W2007305540 hasAuthorship W2007305540A5017868118 @default.
• W2007305540 hasAuthorship W2007305540A5032264474 @default.
• W2007305540 hasAuthorship W2007305540A5052334804 @default.
• W2007305540 hasAuthorship W2007305540A5064465653 @default.
• W2007305540 hasAuthorship W2007305540A5072778971 @default.
• W2007305540 hasAuthorship W2007305540A5073426576 @default.
• W2007305540 hasAuthorship W2007305540A5083304059 @default.
• W2007305540 hasConcept C121608353 @default.
• W2007305540 hasConcept C126322002 @default.
• W2007305540 hasConcept C142724271 @default.
• W2007305540 hasConcept C147990577 @default.
• W2007305540 hasConcept C169760540 @default.
• W2007305540 hasConcept C170493617 @default.
• W2007305540 hasConcept C204232928 @default.
• W2007305540 hasConcept C2776914184 @default.
• W2007305540 hasConcept C2778690821 @default.
• W2007305540 hasConcept C2778857457 @default.
• W2007305540 hasConcept C2779013556 @default.
• W2007305540 hasConcept C502942594 @default.
• W2007305540 hasConcept C71924100 @default.
• W2007305540 hasConcept C86803240 @default.
• W2007305540 hasConceptScore W2007305540C121608353 @default.
• W2007305540 hasConceptScore W2007305540C126322002 @default.
• W2007305540 hasConceptScore W2007305540C142724271 @default.

• next